Both in Pharmaceuticals
Sarepta Therapeutics, vs Schrodinger
Over the past year SRPT returned −22.0% and SDGR returned +35.2%; their daily moves had a correlation of 0.26.
SRPT −22.0% SDGR +35.2%Growth of $1, one year, split-adjusted
| Metric | SRPT | SDGR |
|---|---|---|
| Price | $19.06 | $27.79 |
| Market cap | $2.01B | $2.08B |
| Today | +2.80% | +2.24% |
| 1 month | +10.1% | −3.8% |
| 6 months | −17.2% | +114.1% |
| Year to date | −11.4% | +55.4% |
| 1 year | −22.0% | +35.2% |
| Revenue growth (YoY) | −34.3% | +7.5% |
| Gross margin | 62.8% | 55.1% |
| Net margin | −1.2% | 10.1% |
| P/E (TTM) | — | — |
| Price / sales | 1.0× | 8.0× |
| Net cash | -$59.1M | $413.7M |
| Dividend yield | — | — |
| Volatility (60d) | 61.7% | 94.1% |
| Short % of float | 22.7% | 19.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).